SEP 19, 2016 11:15 AM PDT

PPMO Molecules Enhance Antibiotics' Ability to Fight Superbugs

WRITTEN BY: Carmen Leitch
Bacteria that are resistant to drugs are an ever-increasing public health threat, with the Centers for Disease Control and Prevention (CDC) estimating that antibiotic-resistant bacteria cause over 2 million illnesses; 23,000 of those infections end in death. New work performed at the University of Texas Southwestern Medical Center shows that a synthetic compound can impact a bacterium’s ability to expel antibiotics. This finding could be a promising new way to combat drug-resistant bacteria.
 


Publishing in PLOS Biology, the report shows that this new compound makes bacteria sensitive to drugs they had been resistant to. Bacteria utilize efflux pumps in order to transport materials and those pumps have a big influence on drug resistance. The compound specifically blocks pumps that eliminate antibiotics. To see an animation of efflux pumps, check out the video above.

These findings "potentially have huge implications for clinical infectious diseases," commented Dr. Trish Perl, the Chief of the Division of Infectious Diseases, a Professor of Internal Medicine, and holder of the Jay P. Sanford Professorship in Infectious Diseases at UT Southwestern. "In an era when antibiotic choices are increasingly limited because of resistance, and few new agents are being developed, this becomes a novel and exciting tool that needs to be explored."

The synthetic compound is part of a class of molecules called PPMOs or peptide-conjugated phosphorodiamidate morpholino oligomers that are also called anti-sense molecules because they can bind to complementary sequences of mRNA, which means they can block cellular machinery from making proteins from them. As such, the researchers decided to try to create a PPMO that would target the pump. The compound doesn’t kill bacteria, but by preventing the pump from working, allows the antibiotic to work. For a visual explanation of how antisense drugs work, watch the short video below.
 


"This is just a different strategy," explained Dr. David Greenberg, senior author of the work and an Associate Professor of Internal Medicine and Microbiology at UT Southwestern. "There is a lot of interest in trying to develop new antibiotics, or antibiotics that act in new ways. The other way of thinking about this challenge is to try to make a resistant organism sensitive."

The PPMO created by the team stops the creation of a protein called AcrA, part of an efflux pump complex, AcrAB-TolC, in Escherichia coli (E. coli). The lab of co-senior author Dr. Erdal Toprak previously observed that the AcrAB-TolC complex affects sensitivity to drugs.  When the complex was mutated, drug sensitivity increased.

The molecule made by the investigators, AcrA-PPMO, increased antibiotic efficacy from two to 40-fold in models. Toprak added that some antibiotics thought to be ineffective against E coli were useful when combined with the AcrA-PPMO. Additionally, AcrA-PPMO was demonstrated to work on the pathogens Klebsiella pneumoniae and Salmonella enterica, which share the same efflux pump.

Next, the researchers want to study the PPMO is animal models and against other serious strains of antibiotic-resistant bacteria.

Sources: Phys.org via UT Southwestern Medical Center, CDCPLOS Biology
 
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 04, 2021
Cell & Molecular Biology
A Potential Weakness in SARS-CoV-2 is Caught on Video
MAY 04, 2021
A Potential Weakness in SARS-CoV-2 is Caught on Video
You can see the spike protein of the virus in action in this video.
MAY 13, 2021
Microbiology
The Gut Microbiome Was More Diverse in Ancient People
MAY 13, 2021
The Gut Microbiome Was More Diverse in Ancient People
What can we learn from a specimen of ancient poo? A lot, it turns out. Scientists have now reported their findings from ...
JUN 22, 2021
Clinical & Molecular DX
See the Nasties on Your Skin with Your Smartphone
JUN 22, 2021
See the Nasties on Your Skin with Your Smartphone
The skin is home to around 1.5 trillion bacteria, which together with fungi and viruses, make up the skin microbiota. Th ...
JUN 29, 2021
Microbiology
Gut Fungi May Be an Untapped Reservoir of Antibiotics
JUN 29, 2021
Gut Fungi May Be an Untapped Reservoir of Antibiotics
Viruses are not the only microbes that can cause serious public health problems. Researchers have been warning about a p ...
JUL 12, 2021
Cardiology
Myocarditis in Children is Usually Due to a Virus
JUL 12, 2021
Myocarditis in Children is Usually Due to a Virus
The heart is a muscle, and the wall of the heart has several layers. In a condition called myocarditis, the middle layer ...
JUL 19, 2021
Microbiology
Engineering a Virus Trap
JUL 19, 2021
Engineering a Virus Trap
Viral infections are difficult to treat - antibiotics only work against bacteria - and there are few effective antibodie ...
Loading Comments...